NCT03298542 A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT03270501 Efficacy of Golimumab in Early Axial Spondyloarthritis in Relation to Gut Inflammation Status COMPLETED Phase PHASE3
NCT03253796 Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038) Status COMPLETED Phase PHASE4
NCT03124121 Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels Status COMPLETED Phase PHASE4
NCT03100253 Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation Status TERMINATED Phase PHASE4
NCT03018925 Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis Status COMPLETED Phase N/A
NCT03016260 RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis Status TERMINATED Phase N/A
NCT02846545 A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes Status COMPLETED Phase PHASE2
NCT02841176 Thermography in Assessing Treatment Response to Golimumab in Psoriatic Arthritis Status TERMINATED Phase NA
NCT02758782 NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis Status COMPLETED Phase PHASE4
NCT02425865 Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET Status COMPLETED Phase PHASE4
NCT02414984 Registry for Analysis of Compliance in Colombian Participants With Rheumatoid Arthritis Exposed to Golimumab Status TERMINATED Phase N/A
NCT02412085 Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission Status UNKNOWN Phase PHASE4
NCT02318667 Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022). Status COMPLETED Phase PHASE4
NCT02277444 A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy Status COMPLETED Phase PHASE3
NCT02186886 Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab Status UNKNOWN Phase PHASE4
NCT02186873 A Study of Golimumab in Participants With Active Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT02181673 A Study of Golimumab in Participants With Active Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT02092285 Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032) Status COMPLETED Phase PHASE4
NCT02065713 Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients Status COMPLETED Phase PHASE3